公开(公告)号：US20120302896A1

公开(公告)日：2012-11-29

申请号：US13569147

申请日：2012-08-07

申请人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

发明人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

IPC分类号： A61N1/39 ,  A61B6/00 ,  A61M16/00 ,  A61B5/024

CPC分类号： A61N1/3925 ,  A61B5/0464 ,  A61B5/0535 ,  A61B5/0538 ,  A61B5/7264 ,  A61B7/00 ,  A61B7/04 ,  A61N1/365 ,  A61N1/39 ,  A61N1/3987

摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.

公开(公告)号：US20120029584A1

公开(公告)日：2012-02-02

申请号：US13272733

申请日：2011-10-13

申请人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

发明人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

IPC分类号： A61N1/368 ,  A61N1/39 ,  A61N1/365

CPC分类号： A61N1/3925 ,  A61B5/0464 ,  A61B5/0535 ,  A61B5/0538 ,  A61B5/7264 ,  A61B7/00 ,  A61B7/04 ,  A61N1/365 ,  A61N1/39 ,  A61N1/3987

摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.

公开(公告)号：US08744577B2

公开(公告)日：2014-06-03

申请号：US13569147

申请日：2012-08-07

申请人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

发明人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

IPC分类号： A61N1/365

CPC分类号： A61N1/3925 ,  A61B5/0464 ,  A61B5/0535 ,  A61B5/0538 ,  A61B5/7264 ,  A61B7/00 ,  A61B7/04 ,  A61N1/365 ,  A61N1/39 ,  A61N1/3987

摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.

摘要翻译： 通过评估患者的生理信号来确定患者心脏脉搏的存在。 在一个实施例中，医疗设备评估两个或更多个不同的生理信号，例如心电图（PCG）信号，心电图（ECG）信号，患者阻抗信号，压电信号和加速度计信号，用于指示存在心脏脉搏的特征。 使用这些特征，医疗装置确定患者心脏脉搏是否存在。 除了处于无脉动状态之外，医疗装置还可以被配置为报告患者是否处于VF，VT，心搏停止或PEA状态，并且提示不同的疗法，例如胸部按压，救援呼吸，除颤和 PEA特异性电疗，取决于生理信号的分析。 进一步提供使用起搏刺激自动捕获心脏脉搏。

公开(公告)号：US20120029583A1

公开(公告)日：2012-02-02

申请号：US13267783

申请日：2011-10-06

申请人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

发明人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

IPC分类号： A61N1/39 ,  A61M16/00

CPC分类号： A61N1/3925 ,  A61B5/0464 ,  A61B5/0535 ,  A61B5/0538 ,  A61B5/7264 ,  A61B7/00 ,  A61B7/04 ,  A61N1/365 ,  A61N1/39 ,  A61N1/3987

摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.

公开(公告)号：US20120022339A1

公开(公告)日：2012-01-26

申请号：US13249081

申请日：2011-09-29

申请人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

发明人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

IPC分类号： A61N1/39 ,  A61H31/00 ,  A61N1/00 ,  A61N1/37 ,  A61N1/365 ,  A61M16/00 ,  A61B5/0402 ,  A61B5/1455 ,  A61B5/0464 ,  A61B5/046 ,  A61B5/0245 ,  A61B5/053 ,  A61B5/08 ,  A61B8/02 ,  A61B5/0205

CPC分类号： A61N1/3925 ,  A61B5/0464 ,  A61B5/0535 ,  A61B5/0538 ,  A61B5/7264 ,  A61B7/00 ,  A61B7/04 ,  A61N1/365 ,  A61N1/39 ,  A61N1/3987

摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.

摘要翻译： 通过评估患者的生理信号来确定患者心脏脉搏的存在。 在一个实施例中，医疗设备评估两个或更多个不同的生理信号，例如心电图（PCG）信号，心电图（ECG）信号，患者阻抗信号，压电信号和加速度计信号，用于指示存在心脏脉搏的特征。 使用这些特征，医疗装置确定患者心脏脉搏是否存在。 除了处于无脉动状态之外，医疗装置还可以被配置为报告患者是否处于VF，VT，心搏停止或PEA状态，并且提示不同的疗法，例如胸部按压，救援呼吸，除颤和 PEA特异性电疗，取决于生理信号的分析。 进一步提供使用起搏刺激自动捕获心脏脉搏。

公开(公告)号：US20100121208A1

公开(公告)日：2010-05-13

申请号：US12688684

申请日：2010-01-15

申请人： Ronald E. Stickney ,  James W. Taylor ,  Patricia O'Hearn ,  Cynthia P. Jayne ,  Paula Lank ,  David R. Hampton

发明人： Ronald E. Stickney ,  James W. Taylor ,  Patricia O'Hearn ,  Cynthia P. Jayne ,  Paula Lank ,  David R. Hampton

IPC分类号： A61B5/024

CPC分类号： A61N1/3712 ,  A61B5/024 ,  A61B5/0464 ,  A61B5/0809 ,  A61B5/7239 ,  A61B5/7246 ,  A61B5/7278 ,  A61N1/36521 ,  A61N1/3925

摘要： The presence of a cardiac pulse in a patient is determined by evaluating fluctuations in an electrical signal that represents a measurement of the patient's transthoracic impedance. Impedance signal data obtained from the patient is analyzed for a feature indicative of the presence of a cardiac pulse. Whether a cardiac pulse is present in the patient is determined based on the feature in the impedance signal data. Electrocardiogram (ECG) data may also be obtained in time coordination with the impedance signal data. Various applications for the pulse detection of the invention include detection of PEA and prompting PEA-specific therapy, prompting defibrillation therapy and/or CPR, and prompting rescue breathing depending on detection of respiration.

公开(公告)号：US08532766B2

公开(公告)日：2013-09-10

申请号：US13267783

申请日：2011-10-06

申请人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

发明人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

IPC分类号： A61N1/39

CPC分类号： A61N1/3925 ,  A61B5/0464 ,  A61B5/0535 ,  A61B5/0538 ,  A61B5/7264 ,  A61B7/00 ,  A61B7/04 ,  A61N1/365 ,  A61N1/39 ,  A61N1/3987

摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.

公开(公告)号：US20100121392A1

公开(公告)日：2010-05-13

申请号：US12688712

申请日：2010-01-15

申请人： Ronald E Stickney ,  James W. Taylor ,  Patricia O'Hearn ,  Cynthia P. Jayne ,  Paula Lank ,  David R. Hampton

发明人： Ronald E Stickney ,  James W. Taylor ,  Patricia O'Hearn ,  Cynthia P. Jayne ,  Paula Lank ,  David R. Hampton

IPC分类号： A61N1/39 ,  A61B5/02 ,  A61B5/0472

CPC分类号： A61N1/3712 ,  A61B5/024 ,  A61B5/0464 ,  A61B5/0809 ,  A61B5/7239 ,  A61B5/7246 ,  A61B5/7278 ,  A61N1/36521 ,  A61N1/3925

摘要： The presence of a cardiac pulse in a patient is determined by evaluating fluctuations in an electrical signal that represents a measurement of the patient's transthoracic impedance. Impedance signal data obtained from the patient is analyzed for a feature indicative of the presence of a cardiac pulse. Whether a cardiac pulse is present in the patient is determined based on the feature in the impedance signal data. Electrocardiogram (ECG) data may also be obtained in time coordination with the impedance signal data. Various applications for the pulse detection of the invention include detection of PEA and prompting PEA-specific therapy, prompting defibrillation therapy and/or CPR, and prompting rescue breathing depending on detection of respiration.

摘要翻译： 通过评估表示患者经胸阻抗的测量的电信号中的波动来确定患者心脏脉搏的存在。 分析从患者获得的阻抗信号数据表示存在心脏脉搏的特征。 基于阻抗信号数据中的特征来确定患者心脏脉搏是否存在。 心电图（ECG）数据也可以与阻抗信号数据进行时间协调。 用于本发明的脉搏检测的各种应用包括检测PEA并促进PEA特异性治疗，促进除颤治疗和/或CPR，并且根据呼吸的检测促使救援呼吸。

公开(公告)号：US08239024B2

公开(公告)日：2012-08-07

申请号：US13032250

申请日：2011-02-22

申请人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

发明人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

IPC分类号： A61N1/365

CPC分类号： A61N1/3925 ,  A61B5/0464 ,  A61B5/0535 ,  A61B5/0538 ,  A61B5/7264 ,  A61B7/00 ,  A61B7/04 ,  A61N1/365 ,  A61N1/39 ,  A61N1/3987

摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.

摘要翻译： 通过评估患者的生理信号来确定患者心脏脉搏的存在。 在一个实施例中，医疗设备评估两个或更多个不同的生理信号，例如心电图（PCG）信号，心电图（ECG）信号，患者阻抗信号，压电信号和加速度计信号，用于指示存在心脏脉搏的特征。 使用这些特征，医疗装置确定患者心脏脉搏是否存在。 除了处于无脉动状态之外，医疗装置还可以被配置为报告患者是否处于VF，VT，心搏停止或PEA状态，并且提示不同的疗法，例如胸部按压，救援呼吸，除颤和 PEA特异性电疗，取决于生理信号的分析。 进一步提供使用起搏刺激自动捕获心脏脉搏。

公开(公告)号：US20120035678A1

公开(公告)日：2012-02-09

申请号：US13272703

申请日：2011-10-13

申请人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

发明人： Tae H. Joo ,  Ronald E. Stickney ,  Cynthia P. Jayne ,  Paula Lank ,  Patricia O'Hearn ,  David R. Hampton ,  James W. Taylor ,  William E. Crone ,  Daniel Yerkovich

IPC分类号： A61N1/37

CPC分类号： A61N1/3925 ,  A61B5/0464 ,  A61B5/0535 ,  A61B5/0538 ,  A61B5/7264 ,  A61B7/00 ,  A61B7/04 ,  A61N1/365 ,  A61N1/39 ,  A61N1/3987

摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.